3 Reddit Penny Stocks to Watch Right Now
While Reddit may not be the first place you go to find penny stocks, it should be on your list when doing research. In the past year and a half, Reddit has become a go to place to find trending penny stocks. And while not all penny stocks mentioned on Reddit are worth buying, there are some that could be worth looking into. Of course, investors should still do the proper due diligence before investing in any stocks let alone those on Reddit.
But, it’s worth noting that small-caps frequently talked about online, have become extremely popular this year. One thing to keep in mind is that when a stock is discussed and therefore trending online, it is likely to see more stability and speculation than others. And, this can be worrisome for those investors looking for more stable stocks to buy. However, if volatility is your thing, it could be worth looking into.
While Reddit should never be the only place you go to find stocks, it can be a useful tool in your search. It’s important to remember to never trade with emotion. If you see a stock flying because of its presence online, it may be too late to make a profit. And, if you decide to get in due to FOMO or the fear of missing out, you will more than likely lose money. So, with all of this in mind, let’s take a look at three Reddit penny stocks to watch right now.
3 Reddit Penny Stocks to Watch
- Enzolytics Inc. (OTC: ENZC)
- Akebia Therapeutics Inc. (NASDAQ: AKBA)
- Ebang International Holdings Inc. (NASDAQ: EBON)
Enzolytics Inc. (OTC: ENZC)
Enzolytics Inc. is a biotech penny stock that has been a solid performer over the past few months. This company creates drugs that target and neutralize the HIV virus and other infectious diseases. Currently, Enzolytics Inc. is focused on commercializing its proprietary proteins. The company has clinically tested a great deal of its anti-HIV therapeutics with solid results and promising safety profiles.
On July 20th, Enzolytics announced that it has signed a letter of intent with Creative Biolabs Inc. to license and commercialize anti-HTLV-1 monoclonal antibodies. Creative will test the efficacy and neutralizing capability of the drugs, mass-produce them for marketing and distribution, and promote/market the HTLV-1 mAbs. Deals like these are always important as it is a difficult process to fully commercialize a drug. Even if it gains approval, the manufacturing and distribution stages are always a challenge.
“We now have a comprehensive platform for producing multiple targeted monoclonal antibodies against numerous infectious diseases. This platform includes our ability to identify multiple conserved and immutable sites on viruses to produce fully human monoclonal antibodies targeting those sites. This approach opens the door to new and durable therapies that can be used to treat innumerable human infectious diseases.”The CEO of ENZC, Charles Cotropia
It’s not every day we see a biotech company with a sizable market for a product and potential commercialization on the horizon. Taking note of this recent update, will you add ENZC stock to your watchlist?
Akebia Therapeutics Inc. (NASDAQ: AKBA)
Another biotech penny stock that is performing well in the market right now is Akebia Therapeutics Inc. This is a company that creates therapeutics for those with kidney diseases. Its lead product is known as Vadadustat, which is in Phase 3 trials to treat anemia caused by chronic kidney disease.
The company is developing a variety of other products as well that could have just as large of a potential market size as Vadadustat. As stated earlier, products in the Phase 3 trial stage are close to commercialization. This means that investors should stay up to date with any recent news pertaining to this trial and upcoming ones.
[Read More] 3 Penny Stocks That Exploded Today, One Up 144%
On June 20th, Akebia gave 25 new employees options to purchase a total of 210,000 shares of its common stock. These options were offered at $3.79 per share, which was its closing price on the grant date. While this alone is not major news, insider buying is always important information for investors to understand.
In other recent news, Cylerion Therapeutics Inc. entered an exclusive global license agreement with Akebia to develop and commercialize praliciguat. Akebia is solely responsible for R&D as well as the commercialization for the compound. Cyclerion is eligible for $225 million in pre-commercial milestones, and future milestone payments of up to $585 million. With all of this info in mind, will AKBA enter your list of penny stocks to watch?
Ebang International Holdings Inc. (NASDAQ: EBON)
Tech penny stocks like Ebang International Holdings Inc. have been performing well in the market in the past few months. This is due to a variety of reason including the pandemic, and the general positivity around the tech industry. For some context, this company creates integrated circuit chips and Bitcoin mining machines.
The company additionally provides mining machine hosting services. Its mining machines are offered under the Ebit brand and are sold to companies in the telecommunications and blockchain industries.
In 2021, cryptocurrency has grown significantly in popularity. In fact, blockchain technology and crypto have increased in popularity greatly over the last few years. With cryptos like Bitcoin and DogeCoin exploding in value since the beginning of 2021, there are a lot of eyes on crypto now. NFTs have become a huge market as well, with individual pieces being sold for more than $60 million in some rare cases.
Because of the hype in the market for crypto, EBON stock price has increased. Often EBON stock moves with the crypto market as a whole. So when Bitcoin is down for example, it could potentially hurt EBON stock. With all of this information to keep in mind, will EBON make your list of penny stocks to watch?
Are Reddit Penny Stocks Worth It or Not?
The short answer to this is that it is up to you and your investing strategy. If you’re looking to make short term gains off of speculative stocks, trading penny stocks mentioned on Reddit could be worth it for you.
However, if you are more of a stability investor and one that is looking for long term value, it could be worth avoiding. At the end of the day, knowing your strategy and what type of investor you are will always be a major benefit. Considering this, what do you think? Are Reddit penny stocks worth it or not?nasdaq stocks pandemic cryptocurrency bitcoin blockchain crypto speculative stocks penny stocks otc crypto
Largest Uranium-producing Countries
Which country had the highest uranium production in the world in 2020? Kazakhstan topped the list, followed by Australia and Namibia.
The post Largest Uranium-producing Countries appeared first on Investing News Network.
Output from the top uranium-producing countries rose steadily for a decade, leading to a peak of 63,207 tonnes in 2016. However, global uranium production has noticeably declined in the past five years.
The lower production numbers are related to the persistently low spot price the uranium market has experienced over the last seven years; COVID-19 has also had an impact on global uranium output. While prices have begun to rebound, there is much work to be done for the industry to reach the strength seen prior to the 2011 Fukushima disaster.
The majority of mined uranium makes its way into the nuclear energy sector. Currently, 10 percent of the world’s electricity is generated by nuclear energy, and that number is expected to grow. Another by-product of mined ore is uranium oxide, which is used in glass, ceramics and for optic applications.
10 largest uranium-producing countries
Due to its significance in energy generation, it’s important to know where uranium is mined and which nations are the largest uranium-producing countries.
Kazakhstan is the leader by a long shot, and has been since 2009. Last year, it was followed by Australia and Namibia in second and third place, respectively.
For investors interested in following the uranium space, having familiarity with these uranium production hotspots is essential. Read on to get a closer look at 2020’s largest uranium-producing countries. All statistics are from the World Nuclear Association’s most recent report on uranium mine production.
Mine production: 19,477 tonnes
As mentioned, Kazakhstan had the highest uranium production in the world in 2020. In fact, the country’s total output of 19,477 tonnes accounted for 41 percent of global uranium supply.
When last recorded in 2019, Kazakhstan had 906,800 tonnes of known recoverable uranium resources, second only to Australia. Most of the uranium in the country is mined via an in situ leaching process. Kazataprom (LSE:KAP), the country’s national uranium-mining company, is the world’s largest uranium producer with a number of projects and partnerships in various jurisdictions.
Mine production: 6,203 tonnes
Australia’s uranium production decreased slightly in 2020 to 6,203 tonnes, down from 2019’s 6,613 tonnes. The island nation holds 28 percent of the world’s known recoverable uranium resources.
Uranium mining has been a contentious and often political issue in Australia. While the sector is heavily regulated, the future of the industry is often called into question. Recently, the Western Australian government decided to allow existing projects to go ahead, but was clear that no new domestic uranium-mining projects will be approved. This decision has left a number of companies in limbo.
Australia is home to Olympic Dam, the largest-known deposit of uranium in the world. While the country permits some uranium-mining activity, it is opposed to using nuclear energy. A new partnership between Australia, the US and the UK that will allow the Oceanic country to acquire nuclear submarines has renewed debate over whether the country should develop its own nuclear energy capacity.
Mine production: 5,413 tonnes
Namibia’s uranium production has been steadily increasing after falling to a low of 2,993 tonnes in 2015. In fact, the African nation overtook longtime frontrunner Canada to become the third largest uranium-producing country in 2020, putting out 5,413 tonnes of the material.
The country is home to two uranium mines that are capable of producing 10 percent of the world’s output. Uranium miner Paladin Energy (ASX:PDN,OTCQX:PALAF) owns the Langer Heinrich mine, and mining major Rio Tinto (NYSE:RIO,ASX:RIO,LSE:RIO) controls the majority of the Rössing mine.
In 2017, Paladin took Langer Heinrich offline due to weak uranium prices. In 2020, the uranium spot price began to rise, prompting the uranium miner to ramp up restart efforts.
Mine production: 3,885 tonnes
Canada’s uranium output has fallen dramatically in recent years since hitting a peak of 14,039 tonnes in 2016. After producing 6,938 tonnes of yellowcake in 2019, Canadian uranium production sank to 3,885 tonnes in 2020 as the COVID-19 pandemic led to operational shutdowns.
Uranium exploration is also very prevalent in Canada, with the majority occurring in the uranium-dense Athabasca Basin. That particular area of Saskatchewan is world renowned for its high-quality uranium deposits and friendly mining attitude. The province’s long history with the uranium-mining industry has helped Saskatchewan assert itself as an international leader in the uranium sector.
Mine production: 3,500 tonnes
In 2020, with an estimated 3,500 tonnes of output, Uzbekistan became one of the top five uranium-producing countries. Domestic uranium production has been gradually increasing in the Central Asian nation since 2016. Previously the seventh in terms of global uranium output, it is expanding production via Japanese and Chinese joint ventures.
Navoi Mining & Metallurgy Combinat is part of state holding company Kyzylkumredmetzoloto, and handles all the mining and processing of the domestic uranium supply.
Mine production: 2,991 tonnes
Niger’s uranium production has declined year-over-year over the past decade, with output totaling 2,991 tonnes in 2020. The African nation has two uranium mines in production, SOMAIR and COMINAK, which account for 5.5 percent of the world’s uranium production.
Both projects are operated by subsidiaries of Orano, a private uranium miner with projects in top uranium-producing countries Kazakhstan and Canada.
Niger is also home to the flagship project of explorer GoviEx Uranium (TSXV:GXU,OTCQB:GVXXF). The uranium company is presently developing its Madaeouela asset, as well as projects in Zambia and Mali.
Mine production: 2,846 tonnes
Russia was in seventh place in terms of uranium production in 2020. Output has been steady in the country since 2011, usually coming in near the 3,000 tonne range.
The top uranium-producing country is expected to increase its production in the coming years to meet its energy needs and growing uranium demand around the world. However, Russian uranium has been an area of controversy in recent years, with the US conducting a Section 232 investigation around the security of uranium imports from that region.
In terms of domestic uranium production, Rosatom, a subsidiary of ARMZ Uranium Holding, owns the country’s Priargunsky underground mine and is working on developing the Vershinnoye deposit in Southern Siberia through a subsidiary.
Mine production: 1,885 tonnes
China’s uranium production rose from 885 tonnes in 2011 to 1,885 tonnes in 2018, and has been holding steady since then. China General Nuclear Power, the country’s sole domestic uranium supplier, is looking to expand nuclear fuel supply deals with Kazakhstan and additional foreign uranium companies.
China’s goal is to supply one-third of its nuclear fuel cycle with uranium from domestic producers, obtain one-third through foreign equity in mines and joint ventures overseas and purchase one-third on the open uranium market. China is also leading the way in nuclear energy generation; Mainland China has 51 nuclear reactors with an additional 18 in construction.
Mine production: 400 tonnes
After reaching a high of 1,200 tonnes in 2015, uranium production in Ukraine slid to 800 tonnes in 2016. After a few more years at around the 800 tonne level, output dropped to 400 tonnes in 2020.
Ukraine is heavily dependent on nuclear power, and has 15 reactors that meet about half of the country’s electricity requirements. Most of its uranium demand is met through Russian uranium.
Ukraine holds just 2 percent of the world’s known uranium reserves; in comparison, neighboring Russia accounts for 8 percent of the world’s uranium reserves.
Mine production: 400 tonnes
Rounding out the list is India, which produced 400 tonnes of the energy fuel in 2020. The country’s uranium output has held steady between 300 and 420 tonnes over the past decade.
As of 2018, the country had uranium stockpiles of 71,000 tonnes dedicated to its domestic nuclear energy sector. India currently has 23 operating nuclear reactors with another seven under construction. “The Indian government is committed to growing its nuclear power capacity as part of its massive infrastructure development programme,” according to the World Nuclear Association.
“The government has set ambitious targets to grow nuclear capacity.”
Don’t forget to follow us @INN_Resource for real-time news updates!
Securities Disclosure: I, Melissa Pistilli, hold no direct investment interest in any company mentioned in this article.
Best Dividend Stocks In 2021? 4 To Watch This Week
Dividend stocks to know amidst debates over debt limit and choppy markets.
The post Best Dividend Stocks In 2021? 4 To Watch This Week appeared first on Stock Market News, Quotes, Charts and Financial Information | StockMarket.com.
4 Dividend Stocks Worth Checking Out In A Down Market
As we begin another trading week, dividend stocks are once again at the forefront for investors. For the most part, this could be thanks to various factors, international and domestic, that are weighing on the stock market today. To begin, the market appears to be reacting to significant declines in overseas equities. The likes of which are closely linked to the possible default of a major Chinese real estate company, Evergrande. If anything, this would echo the aftermath of a recent slew of disappointing international economic data influencing the overall recovery trade now.
At the same time, investors could also be treading lightly ahead of the Federal Reserve’s September meeting. The monetary policy meeting would be the launching point for additional debate regarding the Fed’s tapering and overall economic outlook. Now, how would dividend stocks fit into all of this? Simply put, dividend stocks would be a more defensive play in the stock market now. Given the numerous factors contributing to overall volatility across the board, some consistent income in the form of dividends would be appealing.
Accordingly, companies such as Consolidated Edison (NYSE: ED) and Archer-Daniels-Midland (NYSE: ADM) would come into play. This is mostly because of their long history of dividend growth and a constant demand for their services regardless of the current economic cycle. Among the top dividend stocks now are also industry giants that boast massive operations spanning the globe. With all that said, here are four dividend stocks to note now.
Top Dividend Stocks To Buy [Or Sell] This Week
- Apple Inc. (NASDAQ: AAPL)
- 3M Inc. (NYSE: MMM)
- AbbVie Inc. (NYSE: ABBV)
- Microsoft Corporation (NASDAQ: MSFT)
First up, we have Apple, a multinational technology company that manufactures and sells its premium line of tech products. On top of that, it also offers a wide variety of services like its Apple TV+ video-on-demand streaming service and Apple Music. Furthermore, the company is one of the world’s most valuable brands and boasts a high level of brand loyalty among its users. AAPL stock currently trades at $142.94 as of Monday’s close. Its last dividend was declared in July at $0.22 per share.
The company has just recently announced its latest lineup of iPhone models. In fact, its iPhone 13 sales have just begun and millions have already placed orders for them. The company’s lineup this year also packs the latest features like a new A15 processor and 120 Hz display screen on its Pro model.
The company’s deals are also more aggressive this year and have partnered with carriers like T-Mobile (NASDAQ: TMUS) to offer huge incentives for users to trade in their old devices and sign up for a top-shelf cellular plan. Given this exciting piece of news surrounding the company, will you consider adding AAPL stock to your watchlist right now?
[Read More] 4 Semiconductor Stocks To Watch Right Now
The 3M Company
3M is a dividend company that has businesses in consumer goods, health care, worker safety, and industrials. Its products improve lives and help solve the world’s toughest challenges. The company’s portfolio of products includes abrasives and adhesives that are used for construction and are engineered to fit its customers’ needs.
Its array of high-performance materials are used to meet the demands of real-world manufacturing. MMM stock currently trades $180.53 at the end of Monday’s trading session. On August 13, 2021, the company declared a dividend on the company’s common stock of $1.48 per share for the third quarter.
Last week, the company announced that it’s Industrial Adhesives and Tapes Division is evolving its Bonding Process Centers in the U.S., Germany, and China to facilitate the growing trend towards automation in manufacturing. 3M will provide a starting point from which it will design and plan automated bonding solutions. The company will also have sessions to highlight how the company’s growing capabilities can be applied to increase more positive business outcomes for manufacturing and assembly businesses. For these reasons, will you consider MMM stock a buy today?
Following that, we have AbbVie, a company that develops and commercializes advanced therapies. It has over 48,000 employees globally that strive to help patients by providing them next-generation treatments and therapies. It focuses on several key therapeutic areas like immunology, oncology, neuroscience, and eye care among others. ABBV stock trades at $106.40 a share as of Monday’s close and has enjoyed gains of over 18% in the past year.
Today, the company announced that it has submitted an application to the FDA seeking approval for Risankizumab-rzaa, an interleukin-23 inhibitor for the treatment of patients 16 years and older with moderate to severe Crohn’s disease. The company submitted its safety and efficacy data from three Phase 3 studies to the FDA for this approval.
“While there have been advancements in care, many people with Crohn’s disease do not achieve lasting remission,” said Tom Hudson, senior vice president of research and development, chief scientific officer, AbbVie. “This submission is an important step forward in our commitment to providing an additional treatment option for those who struggle with this debilitating and often unpredictable disease.” With that being said, will you consider adding ABBV stock to your portfolio?
[Read More] What Stocks To Buy Today? 5 Tech Stocks To Watch
Another name to consider among dividend stocks in the stock market today would be the Microsoft Corporation. Sure, while Microsoft is not often first on most dividend stock lists, the company is not stingy when it comes to increasing its payouts. Namely, Microsoft has and continues to steadily grow its dividends for about 11 years. Thanks to its latest dividend hike, MSFT stock could be in focus among dividend investors now. As it stands, the company’s shares currently trade at $294.30 as of Monday’s closing bell after gaining 37% year-to-date.
In terms of its dividend, Microsoft announced that it would be boosting its dividend by a whopping 11% last week. While this adds up to a $0.06 per share quarterly payout, investors would be buying into the tech giants’ offerings as well. With pandemic conditions persisting worldwide, demand for Microsoft’s offerings could follow suit.
Even now, the company appears to be kicking into high gear across the board. Together with its dividend hike, Microsoft also plans to initiate a $60 billion share repurchase program, its largest to date. After considering all of this, would MSFT stock be worth investing in?default pandemic nasdaq equities stocks monetary policy fed federal reserve real estate treatment fda recovery germany china
Aurora Cannabis Reschedules Fourth Quarter and Full Fiscal Year 2021 Investor Conference Call and Related Year End Informational Filings to Monday, September 27, 2021
NASDAQ | TSX: ACB
Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has rescheduled its conference call to discuss the results…
NASDAQ | TSX: ACB
Aurora Cannabis Inc. (the “Company” or “Aurora”) (NASDAQ: ACB) (TSX: ACB), the Canadian company defining the future of cannabinoids worldwide, announced today that it has rescheduled its conference call to discuss the results for its fourth quarter and full fiscal year 2021 to Monday, September 27, 2021 at 5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time . The Company will report its financial results for the fourth quarter and full fiscal year 2021, and file its related annual disclosure documents, after the close of markets that same day.
New Conference Call Details
Monday, September 27, 2021
5:00 p.m. Eastern Time | 3:00 p.m. Mountain Time
Miguel Martin , Chief Executive Officer, and Glen Ibbott , Chief Financial Officer, will host the conference call and question and answer period. Investors may submit questions in advance or during the conference call through the weblink listed above. This weblink has also been posted to the Company’s Investor Relations webpage at https://investor.auroramj.com/ under “News & Events”.
Aurora is a global leader in the cannabis industry serving both the medical and consumer markets. Headquartered in Edmonton, Alberta , Aurora is a pioneer in global cannabis dedicated to helping people improve their lives. The Company’s brand portfolio includes Aurora, Aurora Drift, San Rafael ’71, Daily Special, AltaVie, MedReleaf, CanniMed, Whistler, and Reliva CBD. Driven by science and innovation, and with a focus on high-quality cannabis products, Aurora’s brands continue to break through as industry leaders in the medical, performance, wellness and recreational markets wherever they are launched. For more information, please visit our website at www.auroramj.com .
Aurora’s common shares trade on the NASDAQ and TSX under the symbol “ACB” and is a constituent of the S&P/TSX Composite Index.
Forward Looking Statements
This news release includes statements containing certain “forward-looking information” within the meaning of applicable securities law (“forward-looking statements”). Forward-looking statements are frequently characterized by words such as “plan”, “continue”, “expect”, “project”, “intend”, “believe”, “anticipate”, “estimate”, “may”, “will”, “potential”, “proposed” and other similar words, or statements that certain events or conditions “may” or “will” occur. Forward-looking statements made in this news release include statements regarding: the timing for reporting of our financial results for the fourth quarter and full fiscal year 2021 and associated conference call. These forward-looking statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained in the forward-looking statements throughout this news release. Forward looking statements are based on the opinions, estimates and assumptions of management in light of management’s experience and perception of historical trends, current conditions and expected developments at the date the statements are made, such as current and future market conditions, the ability to maintain SG&A costs in line with current expectations, the ability to achieve high margin revenues in the Canadian consumer market, the current and future regulatory environment and future approvals and permits. Forward-looking statements are subject to a variety of risks, uncertainties and other factors that management believes to be relevant and reasonable in the circumstances could cause actual events, results, level of activity, performance, prospects, opportunities or achievements to differ materially from those projected in the forward-looking statements, including the risks associated with: entering the U.S. market, the ability to realize the anticipated benefits associated with the acquisition of Reliva, achievement of Aurora’s business transformation plan, general business and economic conditions, changes in laws and regulations, product demand, changes in prices of required commodities, competition, the effects of and responses to the COVID-19 pandemic and other risks, uncertainties and factors set out under the heading “Risk Factors” in the Company’s annual information form dated September 24, 2020 (the “AIF”) and filed with Canadian securities regulators available on the Company’s issuer profile on SEDAR at www.sedar.com and filed with and available on the SEC’s website at www.edgar.gov . The Company cautions that the list of risks, uncertainties and other factors described in the AIF is not exhaustive and other factors could also adversely affect its results. Readers are urged to consider the risks, uncertainties and assumptions carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such information. The Company is under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as expressly required by applicable securities law.
View original content to download multimedia: https://www.prnewswire.com/news-releases/aurora-cannabis-reschedules-fourth-quarter-and-full-fiscal-year-2021-investor-conference-call-and-related-year-end-informational-filings-to-monday-september-27-2021-301380831.html
SOURCE Aurora Cannabis Inc.
News Provided by PR Newswire via QuoteMedia
Largest Uranium-producing Countries
Weekly Market Review: Stocks Take a Breather Ahead of Fed Meeting
COVID-19 Tests a Boon for Quest Diagnostics
Are Biotech Penny Stocks Worth Buying? Check These 3 Out
Dow Jones, the S&P 500, and Nasdaq weakened amid concerns around tax hikes and possible shifts in the U.S. Federal Reserve’s politics
Best Penny Stocks To Buy? 5 To Watch This Week With Biotech Catalysts
“What On Earth Is Going On In Commodities?”- Morgan Stanley Explains
Top 3 Penny Stocks For Your Weekly Watchlist in September
Here’s why Bitcoin might be safe from a global stock market crisis
Top Penny Stocks to Buy Right Now? 3 to Check Out This Month
Government24 hours ago
If Only We Could Find A Cure For Trump Derangement Syndrome
Stocks4 hours ago
Largest Uranium-producing Countries
Science11 hours ago
Are Biotech Penny Stocks Worth Buying? Check These 3 Out
Economics20 hours ago
Skyrocketing Energy Prices Could Cripple Europe’s Economy
Economics13 hours ago
Bzaar bags $4M to enable US retailers to source home, lifestyle products from India
Government17 hours ago
Markets Set To Drop As Fed “Taper” Approaches
Government17 hours ago
Steyn: A Hinge Moment Of History
Economics7 hours ago
Best Dividend Stocks In 2021? 4 To Watch This Week